Sichuan Kelun Pharmaceutical Co Ltd (002422):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sichuan Kelun Pharmaceutical Co Ltd (002422) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8094
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) is engaged in manufacturing and distribution of IV Solutions. The company’s products portfolio includes glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’s injection, compound amino acid injection, alanyl glutamine injection, compound amino acids, fat emulsion injection, vitamin c and glucose injection, vitamin c and sodium chloride injection, among others. It also offers products to serve parenteral nutrition, digestive system, cardiovascular, antipsychotic, respiratory system, anti-pathogenic microorganisms, and APIs and intermediates. The company is also involved in research and development of pharmaceutical products. Kelun is headquartered in Chengdu, Sichuan, China.

Sichuan Kelun Pharmaceutical Co Ltd (002422) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sichuan Kelun Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Debt Offering 12
Sichuan Kelun Pharma to Raise USD63.3 Million in Private Placement of Bonds Due 2018 12
Sichuan Kelun Pharma Raises USD111.2 Million in Public Offering of 5.65% 2018 Second Tranche Notes 13
Sichuan Kelun Pharma Raises USD79 Million in Public Offering of 6.2% 2018 First Tranche Notes Due 2021 14
Sichuan Kelun Pharma Raises USD210 Million in First Tranche of Public Offering of 5.38% Notes Due 2020 15
Sichuan Kelun Pharma Raises USD206.9 Million in Second Tranche of Public Offering 16
Sichuan Kelun Pharma Raises USD88.6 Million in Public Offering of 5.38% Bonds Due 2020 17
Sichuan Kelun Pharma Raises USD58 Million in Public Offering of 4.89% Bonds Due 2022 18
Sichuan Kelun Pharma Raises USD72.7 Million in Public Offering of Bonds 19
Sichuan Kelun Pharma Completes Public Offering Of Bonds Due 2018 For US$175 Million 20
Sichuan Kelun Pharma Completes Public Offering Of Bonds Due 2017 For US$238 Million 21
Sichuan Kelun Pharma Announces Debt Offering Of Notes Due 2017 For US$412 Million 22
Acquisition 23
Sichuan Kelun Pharma to Acquire Xinjiang-Based Biomedicine company for USD3 Million 23
Sichuan Kelun Pharma Plans to Acquire 35% stake in Changshu-Based Biotechnology Company 24
Sichuan Kelun Pharma Plans to Acquire Remaining 20% stake in Guangxi-Based Pharmaceutical Unit for USD5.3 Million 25
Sichuan Kelun Pharma Acquires KLUS Pharma for USD13 Million 26
Sichuan Kelun Pharma to Acquire 80% Stake in Biotechnology Company 27
Sichuan Kelun Pharma Plans to Acquire Remaining 15% Stake in Zhejiang-based pharmaceutical unit 28
Sichuan Kelun Pharma Acquires Guizhou Kelun Pharma, Pharmaceutical Preparations Manufacturer 29
Sichuan Kelun Pharma Acquires 56% Stake In Chengdu Pharma Company For US$32.8 Million 30
Sichuan Kelun Pharmaceutical Co Ltd – Key Competitors 31
Sichuan Kelun Pharmaceutical Co Ltd – Key Employees 32
Sichuan Kelun Pharmaceutical Co Ltd – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Affiliate 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sichuan Kelun Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Sichuan Kelun Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sichuan Kelun Pharma to Raise USD63.3 Million in Private Placement of Bonds Due 2018 12
Sichuan Kelun Pharma Raises USD111.2 Million in Public Offering of 5.65% 2018 Second Tranche Notes 13
Sichuan Kelun Pharma Raises USD79 Million in Public Offering of 6.2% 2018 First Tranche Notes Due 2021 14
Sichuan Kelun Pharma Raises USD210 Million in First Tranche of Public Offering of 5.38% Notes Due 2020 15
Sichuan Kelun Pharma Raises USD206.9 Million in Second Tranche of Public Offering 16
Sichuan Kelun Pharma Raises USD88.6 Million in Public Offering of 5.38% Bonds Due 2020 17
Sichuan Kelun Pharma Raises USD58 Million in Public Offering of 4.89% Bonds Due 2022 18
Sichuan Kelun Pharma Raises USD72.7 Million in Public Offering of Bonds 19
Sichuan Kelun Pharma Completes Public Offering Of Bonds Due 2018 For US$175 Million 20
Sichuan Kelun Pharma Completes Public Offering Of Bonds Due 2017 For US$238 Million 21
Sichuan Kelun Pharma Announces Debt Offering Of Notes Due 2017 For US$412 Million 22
Sichuan Kelun Pharma to Acquire Xinjiang-Based Biomedicine company for USD3 Million 23
Sichuan Kelun Pharma Plans to Acquire 35% stake in Changshu-Based Biotechnology Company 24
Sichuan Kelun Pharma Plans to Acquire Remaining 20% stake in Guangxi-Based Pharmaceutical Unit for USD5.3 Million 25
Sichuan Kelun Pharma Acquires KLUS Pharma for USD13 Million 26
Sichuan Kelun Pharma to Acquire 80% Stake in Biotechnology Company 27
Sichuan Kelun Pharma Plans to Acquire Remaining 15% Stake in Zhejiang-based pharmaceutical unit 28
Sichuan Kelun Pharma Acquires Guizhou Kelun Pharma, Pharmaceutical Preparations Manufacturer 29
Sichuan Kelun Pharma Acquires 56% Stake In Chengdu Pharma Company For US$32.8 Million 30
Sichuan Kelun Pharmaceutical Co Ltd, Key Competitors 31
Sichuan Kelun Pharmaceutical Co Ltd, Key Employees 32
Sichuan Kelun Pharmaceutical Co Ltd, Subsidiaries 33
Sichuan Kelun Pharmaceutical Co Ltd, Affiliate 34

List of Figures
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sichuan Kelun Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sichuan Kelun Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sichuan Kelun Pharmaceutical Co Ltd (002422):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cielo Wind Power, LP:企業の戦略的SWOT分析
    Cielo Wind Power, LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Euro India Fresh Foods Ltd (EIFFL):企業の財務・戦略的SWOT分析
    Euro India Fresh Foods Ltd (EIFFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Travelsky Technology Ltd (696):企業の財務・戦略的SWOT分析
    Travelsky Technology Ltd (696) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • China Foods Ltd:企業の戦略・SWOT・財務分析
    China Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary China Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Exxon Mobil Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Exxon Mobil Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Exxon Mobil Corp (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petro …
  • Biomatrica Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biomatrica Inc (Biomatrica) is a developer, manufacturer, and supplier of stability technologies preserve biological materials. The company offers DNA, RNA, proteins, cells, and entire assays for diagnostics, research, forensics, biobanks, and sustainability applications. Its products includ …
  • The Chugoku Electric Power Co Inc:発電所・企業SWOT分析
    The Chugoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • National Shipping Company of Saudi Arabia (4030):石油・ガス:M&Aディール及び事業提携情報
    Summary National Shipping Company of Saudi Arabia (Bahri) is a joint stock shipping company, which purchases, charters and operates shipping vessels for the transportation of crude oil, liquefied petroleum gas (LPG), petrochemicals, general cargo, passengers and dry bulk. It operates a fleet of very …
  • EnBW Energie Baden-Wuerttenberg AG:戦略・SWOT・企業財務分析
    EnBW Energie Baden-Wuerttenberg AG - Strategy, SWOT and Corporate Finance Report Summary EnBW Energie Baden-Wuerttenberg AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Celesio AG:企業のM&A・事業提携・投資動向
    Celesio AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Celesio AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Vestas Wind Systems AS (VWS)-エネルギー分野:企業M&A・提携分析
    Summary Vestas Wind Systems A/S (Vestas) is a renewable energy company that designs, manufactures, constructs, installs, and services wind turbines. The company partners with customers to monitor wind energy production and performance of the wind power plant throughout its lifetime. It offers soluti …
  • Fibrocell Science Inc (FCSC):企業の財務・戦略的SWOT分析
    Fibrocell Science Inc (FCSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Hansen Medical Inc (HNSN)-医療機器分野:企業M&A・提携分析
    Summary Hansen Medical Inc (Hansen Medical), formerly Autocath Inc, a subsidiary of Auris Surgical Robotics Inc, is a medical device company that develops, manufactures and markets magellan robotic system for peripheral vascular intervention. The company’s products include robotic system, robotic ca …
  • Whiting Petroleum Corp (WLL):企業の財務・戦略的SWOT分析
    Whiting Petroleum Corp (WLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Innate Immunotherapeutics Ltd (IIL)-製薬・医療分野:企業M&A・提携分析
    Summary Innate Immunotherapeutics Ltd (Innate Immunotherapeutics), formerly Innate Therapeutics Ltd is a medical biotechnology company that develops therapeutic drugs for the treatment of cancer and infectious diseases. The company designs and develops immunomodulator microparticle technology. Innat …
  • Petrobras Argentina S.A.:企業の戦略・SWOT・財務情報
    Petrobras Argentina S.A. - Strategy, SWOT and Corporate Finance Report Summary Petrobras Argentina S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Melkior Resources Inc. (MKR):企業の財務・戦略的SWOT分析
    Melkior Resources Inc. (MKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Bank of America Corporation:企業のM&A・事業提携・投資動向
    Bank of America Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of America Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • CSX Corp (CSX):企業の財務・戦略的SWOT分析
    CSX Corp (CSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆